Analysis of prognostic indicators for dogs with pericardial effusion: 46 cases (1985-1996)

Dianne Dunning From the Department of Clinical Sciences, Veterinary Teaching Hospital, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523-1620.

Search for other papers by Dianne Dunning in
Current site
Google Scholar
PubMed
Close
 DVM, MS
,
Eric Monnet From the Department of Clinical Sciences, Veterinary Teaching Hospital, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523-1620.

Search for other papers by Eric Monnet in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
E. Christopher Orton From the Department of Clinical Sciences, Veterinary Teaching Hospital, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523-1620.

Search for other papers by E. Christopher Orton in
Current site
Google Scholar
PubMed
Close
 DVM, PhD;
, and
M. D. Salman From the Department of Clinical Sciences, Veterinary Teaching Hospital, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523-1620.

Search for other papers by M. D. Salman in
Current site
Google Scholar
PubMed
Close
 BVMS, PhD

Click on author name to view affiliation information

Objective

To determine factors associated with disease-free interval and survival time for dogs with pericardial effusion.

Design

Retrospective study.

Animals

46 dogs.

Procedure

Signalment, history, results of physical examination, electrocardiography, echocardiography, and thoracic radiography; disease-free interval; and survival time were obtained from medical records or telephone conversations with owners and referring veterinarians.

Results

Dogs that had ascites at the time of the initial physical examination were significantly less likely, and dogs that had evidence of pulmonary metastases on thoracic radiographs or that had echocardiographic evidence of a right atrial mass were significantly more likely, to have died of pericardial effusion or the underlying cause of effusion than were dogs that did not. Median survival time was 15.3 months for dogs with idiopathic pericardial effusion, 16 days for dogs with hemangiosarcoma, and 13.6 months for dogs with mesothelioma. Dogs that had a nonspecific extracardiac mass and underwent pericardiectomy were significantly less likely to have had recurrence of signs than were dogs that did not. However, dogs with mesothelioma or hemangiosarcoma that underwent pericardiectomy did not have a significantly different risk of recurrence of signs or survival time, compared with dogs that did not.

Clinical Implications

Results suggest that pericardiectomy will not affect risk of recurrence or survival time in dogs with pericardial effusion secondary to hemangiosarcoma or mesothelioma. However, pericardiectomy is still needed to differentiate dogs with neoplastic pericardial effusion from dogs with idiopathic pericardial effusion. (J Am Vet Med Assoc 1998;212: 1276–1280)

Objective

To determine factors associated with disease-free interval and survival time for dogs with pericardial effusion.

Design

Retrospective study.

Animals

46 dogs.

Procedure

Signalment, history, results of physical examination, electrocardiography, echocardiography, and thoracic radiography; disease-free interval; and survival time were obtained from medical records or telephone conversations with owners and referring veterinarians.

Results

Dogs that had ascites at the time of the initial physical examination were significantly less likely, and dogs that had evidence of pulmonary metastases on thoracic radiographs or that had echocardiographic evidence of a right atrial mass were significantly more likely, to have died of pericardial effusion or the underlying cause of effusion than were dogs that did not. Median survival time was 15.3 months for dogs with idiopathic pericardial effusion, 16 days for dogs with hemangiosarcoma, and 13.6 months for dogs with mesothelioma. Dogs that had a nonspecific extracardiac mass and underwent pericardiectomy were significantly less likely to have had recurrence of signs than were dogs that did not. However, dogs with mesothelioma or hemangiosarcoma that underwent pericardiectomy did not have a significantly different risk of recurrence of signs or survival time, compared with dogs that did not.

Clinical Implications

Results suggest that pericardiectomy will not affect risk of recurrence or survival time in dogs with pericardial effusion secondary to hemangiosarcoma or mesothelioma. However, pericardiectomy is still needed to differentiate dogs with neoplastic pericardial effusion from dogs with idiopathic pericardial effusion. (J Am Vet Med Assoc 1998;212: 1276–1280)

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 334 334 95
PDF Downloads 207 207 82
Advertisement